Saturday, September 17, 2011

PROMISING CANCER RESEARCH: Since last year's Komen Race

Komen Mid-Missouri Race for the Cure 2011   
Sunday, September 18, 2011 - 8:30am
Mizzou Sports Park
Columbia, Missouri 

Breast cancer breakthroughs, 12/2010 to 9/2011
'Systems Biology' Approach Looks Under the Hood of an Aggressive Breast Cancer
Scientists Develop New Therapy for HER2-Positive Breast Cancer
Trastuzumab and Chemotherapy Improved Survival in HER2-Positive Breast Cancer
Targeted Agent Addition to Herceptin Has Positive Effect on Metastatic HER-2 Breast Cancer
Study Finds New Points of Attack on Breast Cancers Not Fueled by Estrogen
National Clinical Trial to Test Novel Approach to Treat Triple-Negative Breast Cancer
New “Nanodrug” Breaks Down Barriers to Attack Breast Cancer Cells from the Inside Out
Study Provides Further Insight Into Racial Disparities in Breast Cancer
Peptide Delivers One-Two Punch to Breast Cancer in Pre-Clinical Study
Combination Therapy Reduced HER2-Positive Breast Cancers

No comments:

Post a Comment